Xing, Li
Lu, Bo
Zhu, Xiangyang
Al Saeedi, Mina
Lerman, Amir
Eirin, Alfonso
Cohen, Pinchas
Lerman, Lilach O. https://orcid.org/0000-0002-3271-3887
Article History
Received: 9 June 2026
Accepted: 11 June 2026
First Online: 22 June 2026
Declarations
Ethics approval and consent to participate: Title of the approved human study: “Obesity-induced mesenchymal stem cell senescence”.Name of the approving ethics committee: Mayo Clinic Institutional Review Board.Ethics approval reference number: 18-005076. Date approved: August 17, 2018.
Consent for publication: Not applicable.
Competing interests: Dr. Lerman is an advisor to CureSpec, LiveKidney.bio, and Cellergy. The authors declare no conflict.